TheStreet Ratings Top 10 Rating Changes

NEW YORK ( TheStreet Ratings) -- Every trading day TheStreet Ratings' stock model reviews the investment ratings on around 4,300 U.S. traded stocks for potential upgrades or downgrades based on the latest available financial results and trading activity.

TheStreet Ratings released rating changes on 42 U.S. common stocks for week ending March 28, 2013. 25 stocks were upgraded and 17 stocks were downgraded by our stock model.

Rating Change #10

ACADIA Pharmaceuticals Inc ( ACAD) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and feeble growth in its earnings per share.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Biotechnology industry. The net income has significantly decreased by 28.5% when compared to the same quarter one year ago, falling from -$5.30 million to -$6.81 million.
  • Net operating cash flow has decreased to -$6.30 million or 17.96% when compared to the same quarter last year. Despite a decrease in cash flow ACADIA PHARMACEUTICALS INC is still fairing well by exceeding its industry average cash flow growth rate of -33.84%.
  • ACADIA PHARMACEUTICALS INC's earnings per share declined by 10.0% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, ACADIA PHARMACEUTICALS INC continued to lose money by earning -$0.37 versus -$0.44 in the prior year. For the next year, the market is expecting a contraction of 2.7% in earnings (-$0.38 versus -$0.37).
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Biotechnology industry and the overall market, ACADIA PHARMACEUTICALS INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • The revenue fell significantly faster than the industry average of 6.8%. Since the same quarter one year prior, revenues fell by 35.4%. The declining revenue appears to have seeped down to the company's bottom line, decreasing earnings per share.
.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a market cap of $654.5 million and is part of the health care sector and drugs industry. Shares are up 77% year to date as of the close of trading on Wednesday.

You can view the full ACADIA Ratings Report or get investment ideas from our investment research center.

Rating Change #9

Federal Agricultural Mortgage Corp ( AGM) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Thrifts & Mortgage Finance industry. The net income has significantly decreased by 26.5% when compared to the same quarter one year ago, falling from $14.04 million to $10.32 million.
  • Net operating cash flow has significantly decreased to -$50.49 million or 380.44% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • AGM, with its decline in revenue, underperformed when compared the industry average of 0.1%. Since the same quarter one year prior, revenues fell by 12.2%. Weakness in the company's revenue seems to have hurt the bottom line, decreasing earnings per share.
  • The gross profit margin for FEDERAL AGRICULTURE MTG CP is currently very high, coming in at 83.80%. Regardless of AGM's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 15.99% trails the industry average.
  • FEDERAL AGRICULTURE MTG CP's earnings per share declined by 29.3% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, FEDERAL AGRICULTURE MTG CP increased its bottom line by earning $3.99 versus $1.21 in the prior year. This year, the market expects an improvement in earnings ($4.61 versus $3.99).
.

Federal Agricultural Mortgage Corporation provides a secondary market for various loans made to borrowers in the United States. The company has a P/E ratio of 8.2, below the S&P 500 P/E ratio of 17.7. Federal Agricultural has a market cap of $300.6 million and is part of the financial sector and financial services industry. Shares are down 0.6% year to date as of the close of trading on Wednesday.

You can view the full Federal Agricultural Ratings Report or get investment ideas from our investment research center.

Rating Change #8

Merit Medical Systems ( MMSI) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and relatively poor performance when compared with the S&P 500 during the past year.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • MMSI's revenue growth has slightly outpaced the industry average of 8.5%. Since the same quarter one year prior, revenues rose by 12.2%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • Net operating cash flow has significantly increased by 178.42% to $14.78 million when compared to the same quarter last year. In addition, MERIT MEDICAL SYSTEMS INC has also vastly surpassed the industry average cash flow growth rate of 8.25%.
  • The gross profit margin for MERIT MEDICAL SYSTEMS INC is rather high; currently it is at 51.00%. Regardless of MMSI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, MMSI's net profit margin of 0.62% is significantly lower than the industry average.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 87.1% when compared to the same quarter one year ago, falling from $4.97 million to $0.64 million.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. In comparison to the other companies in the Health Care Equipment & Supplies industry and the overall market, MERIT MEDICAL SYSTEMS INC's return on equity is significantly below that of the industry average and is below that of the S&P 500.
.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical devices for use in interventional and diagnostic procedures worldwide. The company has a P/E ratio of 26.7, above the S&P 500 P/E ratio of 17.7. Merit Medical Systems has a market cap of $523.1 million and is part of the health care sector and health services industry. Shares are down 11.4% year to date as of the close of trading on Tuesday.

You can view the full Merit Medical Systems Ratings Report or get investment ideas from our investment research center.

Rating Change #7

QLogic Corporation ( QLGC) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and unimpressive growth in net income.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • QLGC has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 7.46, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for QLOGIC CORP is currently very high, coming in at 73.60%. Regardless of QLGC's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, QLGC's net profit margin of 11.09% is significantly lower than the industry average.
  • QLOGIC CORP's earnings per share declined by 48.3% in the most recent quarter compared to the same quarter a year ago. Earnings per share have declined over the last year. We anticipate that this should continue in the coming year. During the past fiscal year, QLOGIC CORP reported lower earnings of $1.16 versus $1.28 in the prior year. For the next year, the market is expecting a contraction of 31.9% in earnings ($0.79 versus $1.16).
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Computers & Peripherals industry. The net income has significantly decreased by 55.9% when compared to the same quarter one year ago, falling from $30.03 million to $13.24 million.
.

QLogic Corporation designs and supplies network infrastructure products that provide, enhance, and manage computer data communication. The company has a P/E ratio of 15.7, below the S&P 500 P/E ratio of 17.7. QLogic has a market cap of $1.07 billion and is part of the technology sector and electronics industry. Shares are up 19.2% year to date as of the close of trading on Thursday.

You can view the full QLogic Ratings Report or get investment ideas from our investment research center.

Rating Change #6

Saratoga Resources Inc ( SARA) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally high debt management risk and generally disappointing historical performance in the stock itself.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Oil, Gas & Consumable Fuels industry. The net income has significantly decreased by 125.0% when compared to the same quarter one year ago, falling from $11.48 million to -$2.87 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Oil, Gas & Consumable Fuels industry and the overall market, SARATOGA RESOURCES INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has decreased to $12.07 million or 22.15% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm's growth is significantly lower.
  • The debt-to-equity ratio is very high at 2.41 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Regardless of the company's weak debt-to-equity ratio, SARA has managed to keep a strong quick ratio of 1.79, which demonstrates the ability to cover short-term cash needs.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 62.63%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 123.25% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
.

Saratoga Resources, Inc., an independent oil and natural gas company, engaged in the acquisition, exploitation, development, and production of crude oil and natural gas properties in the United States. The company has a P/E ratio of 6.4, below the S&P 500 P/E ratio of 17.7. Saratoga has a market cap of $83.1 million and is part of the basic materials sector and energy industry. Shares are down 24% year to date as of the close of trading on Thursday.

You can view the full Saratoga Ratings Report or get investment ideas from our investment research center.

Rating Change #5

Forestar Group Inc ( FOR) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The revenue growth came in higher than the industry average of 15.1%. Since the same quarter one year prior, revenues rose by 27.0%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • The current debt-to-equity ratio, 0.56, is low and is below the industry average, implying that there has been successful management of debt levels.
  • FORESTAR GROUP INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, FORESTAR GROUP INC increased its bottom line by earning $0.36 versus $0.19 in the prior year. This year, the market expects an improvement in earnings ($0.63 versus $0.36).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Real Estate Management & Development industry. The net income increased by 143.8% when compared to the same quarter one year prior, rising from -$22.88 million to $10.03 million.
  • Powered by its strong earnings growth of 143.07% and other important driving factors, this stock has surged by 43.39% over the past year, outperforming the rise in the S&P 500 Index during the same period. We feel that the stock's sharp appreciation over the last year has driven it to a price level which is now somewhat expensive compared to the rest of its industry. The other strengths this company shows, however, justify the higher price levels.
.

Forestar Group Inc. operates as a real estate and natural resources company. The company operates in three segments: Real Estate, Mineral Resources, and Fiber Resources. The company has a P/E ratio of 62.4, above the S&P 500 P/E ratio of 17.7. Forestar Group has a market cap of $777.3 million and is part of the financial sector and real estate industry. Shares are up 28.4% year to date as of the close of trading on Thursday.

You can view the full Forestar Group Ratings Report or get investment ideas from our investment research center.

Rating Change #4

Mattress Firm Holding Corp ( MFRM) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • MFRM's very impressive revenue growth exceeded the industry average of 26.1%. Since the same quarter one year prior, revenues leaped by 50.8%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • MATTRESS FIRM HOLDING CORP has improved earnings per share by 5.7% in the most recent quarter compared to the same quarter a year ago. This year, the market expects an improvement in earnings ($1.50 versus $0.97).
  • MFRM has underperformed the S&P 500 Index, declining 8.51% from its price level of one year ago.
  • The company, on the basis of net income growth from the same quarter one year ago, has significantly underperformed compared to the Specialty Retail industry average, but is greater than that of the S&P 500. The net income increased by 1.1% when compared to the same quarter one year prior, going from $12.31 million to $12.46 million.
  • MFRM's debt-to-equity ratio of 0.90 is somewhat low overall, but it is high when compared to the industry average, implying that the management of the debt levels should be evaluated further. Even though the debt-to-equity ratio shows mixed results, the company's quick ratio of 0.29 is very low and demonstrates very weak liquidity.
.

Mattress Firm Holding Corp., through its subsidiaries, engages in the retail sale of mattresses, and related products and accessories in the United States. The company has a P/E ratio of 22.4, above the S&P 500 P/E ratio of 17.7. Mattress Firm has a market cap of $1.06 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 31.1% year to date as of the close of trading on Tuesday.

You can view the full Mattress Firm Ratings Report or get investment ideas from our investment research center.

Rating Change #3

Pitney Bowes Inc ( PBI) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • Compared to other companies in the Commercial Services & Supplies industry and the overall market, PITNEY BOWES INC's return on equity significantly exceeds that of both the industry average and the S&P 500.
  • Net operating cash flow has increased to $220.56 million or 29.93% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -18.82%.
  • The gross profit margin for PITNEY BOWES INC is rather high; currently it is at 56.10%. Regardless of PBI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, PBI's net profit margin of 8.57% compares favorably to the industry average.
  • Regardless of the drop in revenue, the company managed to outperform against the industry average of 9.6%. Since the same quarter one year prior, revenues slightly dropped by 1.4%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.
  • PITNEY BOWES INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. However, we anticipate underperformance relative to this pattern in the coming year. During the past fiscal year, PITNEY BOWES INC increased its bottom line by earning $2.18 versus $1.98 in the prior year. For the next year, the market is expecting a contraction of 11.9% in earnings ($1.92 versus $2.18).
.

Pitney Bowes Inc. provides software, hardware, and services to enable physical and digital communications in the United States and internationally. The company has a P/E ratio of seven, below the S&P 500 P/E ratio of 17.7. Pitney Bowes has a market cap of $3.03 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 41% year to date as of the close of trading on Tuesday.

You can view the full Pitney Bowes Ratings Report or get investment ideas from our investment research center.

Rating Change #2

Pengrowth Energy Corp ( PGH) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and generally higher debt management risk.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • PGH's very impressive revenue growth greatly exceeded the industry average of 2.0%. Since the same quarter one year prior, revenues leaped by 68.9%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Oil, Gas & Consumable Fuels industry. The net income increased by 151.7% when compared to the same quarter one year prior, rising from -$8.97 million to $4.64 million.
  • Net operating cash flow has slightly increased to $207.68 million or 1.53% when compared to the same quarter last year. Despite an increase in cash flow, PENGROWTH ENERGY CORP's cash flow growth rate is still lower than the industry average growth rate of 26.26%.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Oil, Gas & Consumable Fuels industry and the overall market, PENGROWTH ENERGY CORP's return on equity significantly trails that of both the industry average and the S&P 500.
  • PGH's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 46.86%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Although its share price is down sharply from a year ago, do not assume that it can now be tagged as cheap and attractive. The reality is that, based on its current price in relation to its earnings, PGH is still more expensive than most of the other companies in its industry.
.

Pengrowth Energy Corporation engages in the acquisition, exploration, development, and production of oil and natural gas reserves in Canada. The company has a P/E ratio of 173.3, above the S&P 500 P/E ratio of 17.7. Pengrowth Energy has a market cap of $2.67 billion and is part of the basic materials sector and energy industry. Shares are up 3.8% year to date as of the close of trading on Thursday.

You can view the full Pengrowth Energy Ratings Report or get investment ideas from our investment research center.

Rating Change #1

Rosetta Stone Inc ( RST) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's return on equity has been disappointing.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • Powered by its strong earnings growth of 175.00% and other important driving factors, this stock has surged by 46.62% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, our hold rating indicates that we do not recommend additional investment in this stock despite its gains in the past year.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Software industry. The net income increased by 180.4% when compared to the same quarter one year prior, rising from -$4.98 million to $4.01 million.
  • ROSETTA STONE INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, ROSETTA STONE INC reported poor results of -$1.71 versus -$0.97 in the prior year. This year, the market expects an improvement in earnings ($0.04 versus -$1.71).
  • The gross profit margin for ROSETTA STONE INC is currently very high, coming in at 83.60%. Regardless of RST's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, RST's net profit margin of 5.09% is significantly lower than the industry average.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Software industry and the overall market, ROSETTA STONE INC's return on equity significantly trails that of both the industry average and the S&P 500.
.

Rosetta Stone Inc., together with its subsidiaries, provides technology-based language-learning solutions in the United States and internationally. Rosetta Stone has a market cap of $310.8 million and is part of the technology sector and computer software & services industry. Shares are up 21.3% year to date as of the close of trading on Wednesday.

You can view the full Rosetta Stone Ratings Report or get investment ideas from our investment research center.

-- Reported by Kevin Baker in Palm Beach Gardens, Fla.

For additional Investment Research check out our Ratings Research Center.

For all other upgrades and downgrades made by TheStreet Ratings Model today check out our upgrades and downgrades list.

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Kevin Baker became the senior financial analyst for TheStreet Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering equity and mutual fund ratings. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.

More from Investing

What Is a Bear Market and What Does it Mean in 2018?

What Is a Bear Market and What Does it Mean in 2018?

FedEx Tanks After It Fails to Deliver on Earnings

FedEx Tanks After It Fails to Deliver on Earnings

FedEx's Free Cash Flow Offers a Positive Signal for a Sagging Stock

FedEx's Free Cash Flow Offers a Positive Signal for a Sagging Stock

Facebook, Banks Went Back and Forth Over User Data: LIVE MARKETS BLOG

Facebook, Banks Went Back and Forth Over User Data: LIVE MARKETS BLOG

Today's Market Was Primarily Fueled by Bad Positioning

Today's Market Was Primarily Fueled by Bad Positioning